13F HOLDINGS REPORT
MPM ASSET MANAGEMENT LLC
Quarter ended Q1 2025 · Filed May 15, 2025 · Accession 0000950123-25-005757
Total Value
$69.4M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Entrada Therapeutics, Inc. | TRDA | 4,381,062 | $39.6M | 57.04% |
| 2 | iTeos Therapeutics, Inc. | 46565G104 | 2,738,785 | $16.4M | 23.55% |
| 3 | Dyne Therapeutics, Inc. | DYN | 682,376 | $7.1M | 10.28% |
| 4 | Werewolf Therapeutics, Inc. | HOWL | 4,309,860 | $4.2M | 6.03% |
| 5 | Repare Therapeutics, Inc. | 760273102 | 1,121,318 | $1.1M | 1.59% |
| 6 | Adaptimmune Therapeutics plc | ADTI | 5,335,715 | $1.1M | 1.51% |